<DOC>
	<DOCNO>NCT00731185</DOCNO>
	<brief_summary>This study conduct evaluate effectiveness mometasone nasal spray prevent polyp relapse/symptom worsen patient surgical treatment nasal polyp . Patients meet Screening eligibility underwent endoscopic sino-nasal surgery ( FESS ) visit 2 . Mometasone nasal spray placebo start 2 week surgery continue 24 week relapse .</brief_summary>
	<brief_title>Mometasone Furoate Nasal Spray Treatment Nasal Polyposis After Surgery ( Study P03218 )</brief_title>
	<detailed_description />
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>At least 18 year age Bilateral nasal polyp Fulfill criterion polypectomy ( indicated surgical FESS treatment ) Polypectomy within last 6 month Unhealed nasal surgery/trauma &gt; 5 previous polypectomy Female childbearing age pregnant , lactating , use active contraceptive method Nasal infection Pulmonary tuberculosis Cystic fibrosis , glaucoma , clinically significant cardiovascular , pulmonary , renal , hepatic , metabolic , hematological , neurological disease Immunocompromised Rhinitis medicamentosa ( rebound congestion follow misuse nasal decongestant ) Known hereditary mucociliary dysfunction Significant nasal structure abnormalities Asthmatic attack within past 30 day Asthmatic patient require &gt; 1000 mcg beclomethasone equivalent Asthmatic patient stable corticosteroid therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>functional</keyword>
	<keyword>endoscopic</keyword>
	<keyword>sinus</keyword>
	<keyword>surgery</keyword>
</DOC>